For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumor shrinkage and adds a modest improvement in progression-free survival, researchers report.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/k...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/k...